|
OSBPL10 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.631600E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.550400E-01 |
| Normal-vs-Stage2 |
7.802100E-03 |
| Normal-vs-Stage3 |
9.649100E-04 |
| Normal-vs-Stage4 |
7.854600E-01 |
| Stage1-vs-Stage2 |
4.123900E-02 |
| Stage1-vs-Stage3 |
7.723000E-03 |
| Stage1-vs-Stage4 |
9.878600E-01 |
| Stage2-vs-Stage3 |
9.486000E-01 |
| Stage2-vs-Stage4 |
4.230200E-01 |
| Stage3-vs-Stage4 |
4.248200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.168200E-02 |
| Normal-vs-AfricanAmerican |
5.709400E-01 |
| Normal-vs-Asian |
8.350800E-01 |
| Caucasian-vs-AfricanAmerican |
5.025400E-01 |
| Caucasian-vs-Asian |
6.079400E-01 |
| AfricanAmerican-vs-Asian |
6.710200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.495800E-03 |
| Normal-vs-Female |
5.900200E-01 |
| Male-vs-Female |
3.655600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.493400E-01 |
| Normal-vs-Age(41-60Yrs) |
4.913600E-01 |
| Normal-vs-Age(61-80Yrs) |
1.492060E-02 |
| Normal-vs-Age(81-100Yrs) |
8.551900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.625600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.738600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.756000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.368000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.025000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.904200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.628200E-01 |
| Normal-vs-Grade 2 |
7.873800E-02 |
| Normal-vs-Grade 3 |
5.065400E-01 |
| Normal-vs-Grade 4 |
2.121900E-03 |
| Grade 1-vs-Grade 2 |
1.414630E-01 |
| Grade 1-vs-Grade 3 |
2.032800E-01 |
| Grade 1-vs-Grade 4 |
2.464000E-02 |
| Grade 2-vs-Grade 3 |
6.893400E-01 |
| Grade 2-vs-Grade 4 |
4.808000E-02 |
| Grade 3-vs-Grade 4 |
8.715800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.334300E-02 |
| Normal-vs-ccB subtype |
2.907600E-01 |
| ccA subtype-vs-ccB subtype |
4.981600E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.154200E-02 |
| Normal-vs-N1 |
4.338400E-01 |
| N0-vs-N1 |
9.018800E-01 |
|
|
